Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure a report on behalf of the MDS clinical research consortium

Elias J. Jabbour, Guillermo Garcia-Manero, Paolo Strati, Asmita Mishra, Najla H. Al Ali, Eric Padron, Jeffrey Lancet, Tapan Kadia, Naval Daver, Susan O'Brien, David P. Steensma, Mikkael A. Sekeres, Steven D. Gore, Amy Dezern, Gail J. Roboz, Alan F. List, Hagop M. Kantarjian, Rami S. Komrokji

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure a report on behalf of the MDS clinical research consortium'. Together they form a unique fingerprint.

Medicine & Life Sciences